EUVIMEDEUVIMED entdecken
Crossref

Accelerated Partial Breast Irradiation for Low-Risk Hormone-Sensitive Breast Cancer: Trends and Underutilization in the National Cancer Database 2010-2022

Shengyang Peter Wu, Scott M Glaser, Stephanie Yoon, Colton Ladbury, Amanda L Schwer, Kelly Yap, Katharine Schulz-Costello, Jamie Rand, Jose G Bazan

Practical Radiation Oncology · 2026-11 · 16 (6) · 563-573

DOI: 10.1016/j.prro.2026.04.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Practical Radiation Oncology, 2026-11. Verfasst von Shengyang Peter Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, City of Hope Comprehensive Cancer Center, Duarte, California. Hauptthemen laut MEDLINE: Breast Neoplasms, Brachytherapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Despite growing evidence supporting the use of accelerated partial breast irradiation (APBI) and partial breast irradiation (PBI) for early-stage, low-risk breast cancer, utilization remains limited. This study evaluates trends and geographic variations in APBI/PBI adoption within the National Cancer Database from 2010 to 2022. METHODS AND MATERIALS: We used the National Cancer Database to identify patients who underwent margin-negative lumpectomy and radiation from 2010 to 2022 with favorable breast cancer: age ≥50 years, hormone receptor-positive/human epidermal growth factor receptor 2-negative, pathologic T1N0, grade 1-2, and nonlobular histology. Patients were stratified by the type of radiation therapy (APBI or whole breast irradiation [WBI]). The primary outcome was the annual utilization rate of accelerated partial breast irradiation (APBI/PBI) compared with WBI. RESULTS: Overall, 256,549 patients met all eligibility criteria. In this cohort, 31,154 (12.1%) received APBI/PBI. The use of APBI/PBI increased from 7.5% (2010-2017) to 16.2% (2018-2022) (P < .001). In the final year, among the 26,124 patients analyzed, 6100 (23.3%) received any form of APBI/PBI, and 4778 (18.2%) were treated with either 30 Gy/5Fx external beam APBI or brachytherapy. CONCLUSIONS: We found a significant rise in APBI/PBI use in patients with low-risk hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer. Despite the increasing trend, even in the most recent year, fewer than 1 in 4 potentially eligible patients received APBI/PBI. Among patients treated in 2022, fewer than 1 in 5 patients received 30 Gy/5Fx external beam APBI or brachytherapy, the 2 forms of APBI that possess the combination of similar cancer control outcomes, greater convenience, and less toxicity compared with WBI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsBrachytherapyHumansFemaleMiddle AgedDatabases, FactualAgedMastectomy, SegmentalUnited States

Autor:innen und Institutionen

  • Department of Radiation Oncology, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Department of Surgery, Division of Breast Surgery, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Department of Radiation Oncology, City of Hope Comprehensive Cancer Center, Duarte, California. Electronic address: jbazan@coh.org.

Zitieren

APA

Wu, S. P., Glaser, S. M., Yoon, S., Ladbury, C., Schwer, A. L., Yap, K., Schulz-Costello, K., Rand, J., & Bazan, J. G. (2026). Accelerated Partial Breast Irradiation for Low-Risk Hormone-Sensitive Breast Cancer: Trends and Underutilization in the National Cancer Database 2010-2022. Practical Radiation Oncology, 16(6), 563-573. https://doi.org/10.1016/j.prro.2026.04.012

Vancouver

Wu SP, Glaser SM, Yoon S, Ladbury C, Schwer AL, Yap K, et al. Accelerated Partial Breast Irradiation for Low-Risk Hormone-Sensitive Breast Cancer: Trends and Underutilization in the National Cancer Database 2010-2022. Practical Radiation Oncology. 2026;16(6):563-573. doi:10.1016/j.prro.2026.04.012

BibTeX
@article{Wu2026,
  author = {Wu, Shengyang Peter and Glaser, Scott M and Yoon, Stephanie and Ladbury, Colton and Schwer, Amanda L and Yap, Kelly and Schulz-Costello, Katharine and Rand, Jamie and Bazan, Jose G},
  title = {Accelerated Partial Breast Irradiation for Low-Risk Hormone-Sensitive Breast Cancer: Trends and Underutilization in the National Cancer Database 2010-2022},
  journal = {Practical Radiation Oncology},
  year = {2026},
  volume = {16},
  number = {6},
  pages = {563--573},
  doi = {10.1016/j.prro.2026.04.012}
}
Kostenlos starten →